Hims and Hers launches weight-loss drugs in Australia

Telehealth provider Hims and Hers has launched branded GLP-1 weight-loss drugs and other treatments in Australia. The move follows its acquisition of local digital health platform Eucalyptus. The company also plans to introduce a women health segment later this year.

Xurve View
Insights:
The company logo for Hims & Hers Health, Inc is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., August 17, 2026. REUTERS/Brendan McDermid

HIMS & HERS HEALTH INC expanded its international reach on Monday, offering branded GLP-1 weight-loss drugs in Australia. The telehealth provider aims to capture a larger share of the global preventative care market. International expansion has boosted subscriptions but weighed on gross profit margins.